tetradecanoylphorbol acetate has been researched along with deoxycytidine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ban, J; Weber, G | 1 |
Harris, CC; Masui, T; Smith, RA; Wilson, VL | 1 |
Bondy, GP; Denhardt, DT | 1 |
Mastro, AM; Pepin, KG | 1 |
Huang, P; Plunkett, W | 1 |
Cartee, L; Kucera, GL; Nixon, JB | 1 |
Dent, P; Grant, S; Kramer, LB; Povirk, LF; Saunders, AM; Vrana, JA; Zhang, XF | 1 |
Conney, AH; Cui, XX; Gao, Z; Huang, MT; Liu, Y; Rabson, AB; Verano, M; Zheng, X | 1 |
8 other study(ies) available for tetradecanoylphorbol acetate and deoxycytidine
Article | Year |
---|---|
Synergistic action of tiazofurin and difluorodeoxycytidine on differentiation and cytotoxicity.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Differentiation; Cell Line; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Female; Gemcitabine; Humans; IMP Dehydrogenase; Kinetics; Leukemia, Promyelocytic, Acute; Liver Neoplasms, Experimental; Models, Biological; Ovarian Neoplasms; Pancreatic Neoplasms; Rats; Ribavirin; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Stem Cell Assay | 1992 |
Genomic 5-methyldeoxycytidine decreases associated with the induction of squamous differentiation in cultured normal human bronchial epithelial cells.
Topics: Azacitidine; Bronchi; Cell Differentiation; Cells, Cultured; Deoxycytidine; DNA; Epithelium; Humans; Tetradecanoylphorbol Acetate; Transforming Growth Factors | 1988 |
Exposure of JB-6 mouse epidermal cells to 12-O-tetradecanoyl-phorbol-13-acetate is not accompanied by a significant change in total DNA-cytosine methylation.
Topics: 5-Methylcytosine; Animals; Cell Line; Chromatography, High Pressure Liquid; Cytosine; Deoxycytidine; DNA; Mice; Phorbols; Skin; Tetradecanoylphorbol Acetate | 1983 |
[3H] thymidine incorporation in bovine lymphocytes treated with the tumor promoter, 12-O-tetradecanoyl phorbol-13-acetate.
Topics: Animals; Cattle; Cells, Cultured; Deoxycytidine; DNA; Lymph Nodes; Lymphocytes; Phorbols; Phytohemagglutinins; Tetradecanoylphorbol Acetate; Thymidine; Tritium | 1981 |
Induction of apoptosis by gemcitabine.
Topics: Aphidicolin; Apoptosis; Calcium; Carcinogens; Chelating Agents; Clone Cells; Deoxycytidine; DNA; Egtazic Acid; Enzyme Inhibitors; Flow Cytometry; Gemcitabine; Humans; Ribonucleotide Reductases; S Phase; Tetradecanoylphorbol Acetate | 1995 |
The effects of gemcitabine and TPA on PKC signaling in BG-1 human ovarian cancer cells.
Topics: Alkaline Phosphatase; Antimetabolites, Antineoplastic; Blotting, Western; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Isoenzymes; Mitogen-Activated Protein Kinase 1; Ovarian Neoplasms; Protein Kinase C; Subcellular Fractions; Tetradecanoylphorbol Acetate; Time Factors; Tumor Cells, Cultured | 1998 |
Inhibition of protein kinase C activator-mediated induction of p21CIP1 and p27KIP1 by deoxycytidine analogs in human leukemia cells: relationship to apoptosis and differentiation.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Bryostatins; Cell Cycle Proteins; Cell Differentiation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cytarabine; Deoxycytidine; Drug Interactions; Enzyme Activation; Gemcitabine; Humans; Lactones; Leukemia; Macrolides; Microtubule-Associated Proteins; Mitogens; Protein Kinase C; Tetradecanoylphorbol Acetate; Tumor Suppressor Proteins; U937 Cells | 1999 |
Effects of 12-O-tetradecanoylphorbol-13-acetate in combination with gemcitabine on Panc-1 pancreatic cancer cells cultured in vitro or Panc-1 tumors grown in immunodeficient mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Enzyme Activation; Female; Gemcitabine; Humans; MAP Kinase Kinase 4; Mice; Mice, Nude; Pancreatic Neoplasms; Tetradecanoylphorbol Acetate; Xenograft Model Antitumor Assays | 2012 |